BR9913490A - Prosaposina cìclicos e seus usos - Google Patents

Prosaposina cìclicos e seus usos

Info

Publication number
BR9913490A
BR9913490A BR9913490-0A BR9913490A BR9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A
Authority
BR
Brazil
Prior art keywords
cyclic
prosaposine
derived
peptides
saposin
Prior art date
Application number
BR9913490-0A
Other languages
English (en)
Portuguese (pt)
Inventor
David E Wright
John
S O'obrien
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of BR9913490A publication Critical patent/BR9913490A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
BR9913490-0A 1998-08-28 1999-08-20 Prosaposina cìclicos e seus usos BR9913490A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Publications (1)

Publication Number Publication Date
BR9913490A true BR9913490A (pt) 2001-09-25

Family

ID=22268937

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913490-0A BR9913490A (pt) 1998-08-28 1999-08-20 Prosaposina cìclicos e seus usos

Country Status (13)

Country Link
EP (1) EP1105420A1 (cg-RX-API-DMAC7.html)
JP (2) JP4528443B2 (cg-RX-API-DMAC7.html)
KR (1) KR20010079695A (cg-RX-API-DMAC7.html)
CN (1) CN1324367A (cg-RX-API-DMAC7.html)
AU (1) AU751034B2 (cg-RX-API-DMAC7.html)
BR (1) BR9913490A (cg-RX-API-DMAC7.html)
CA (1) CA2341810A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ2001655A3 (cg-RX-API-DMAC7.html)
HU (1) HUP0103265A3 (cg-RX-API-DMAC7.html)
IL (1) IL141586A0 (cg-RX-API-DMAC7.html)
PL (1) PL204359B1 (cg-RX-API-DMAC7.html)
WO (1) WO2000012553A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200102489B (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
WO2000012553A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
EP2020988B1 (en) 2006-04-28 2017-08-16 Children's Hospital Medical Center Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
CA2666953A1 (en) * 2006-10-20 2008-05-02 Children's Hospital Medical Center Spontaneous forming ellipsoidal phospholipid unilamellar vesicles
CN103275187B (zh) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 一种镇痛肽fi及其基因和应用
JP7066412B2 (ja) 2015-04-23 2022-05-13 ザ プロクター アンド ギャンブル カンパニー 界面活性剤可溶性抗ふけ剤の送達
CN108697609A (zh) 2016-03-03 2018-10-23 宝洁公司 气溶胶去头皮屑组合物
WO2018075846A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam designating hair conditioning benefits
US20180110688A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated Shampoo Dosage of Foam for Providing Hair Care Benefits
WO2018075850A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume and surfactant amount in an optimal formulation space
CN109843252A (zh) 2016-10-21 2019-06-04 宝洁公司 指定毛发体积有益效果的浓缩型洗发剂泡沫剂型
WO2018075855A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
EP3528780A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Stable compact shampoo products with low viscosity and viscosity reducing agent
EP3528896A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US20190105246A1 (en) 2017-10-10 2019-04-11 The Procter & Gamble Company Sulfate free personal cleansing composition comprising low inorganic salt
EP3694479A1 (en) 2017-10-10 2020-08-19 The Procter and Gamble Company A method of treating hair or skin with a personal care composition in a foam form
WO2019074989A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company COMPACT SHAMPOO COMPOSITION CONTAINING SULFATE-FREE SURFACTANTS
US11116705B2 (en) 2017-10-10 2021-09-14 The Procter And Gamble Company Compact shampoo composition containing sulfate-free surfactants
CN111556743B (zh) 2017-12-20 2023-07-18 宝洁公司 包含硅氧烷聚合物的澄清洗发剂组合物
CN112367963A (zh) 2018-06-29 2021-02-12 宝洁公司 低表面活性剂气溶胶去头皮屑组合物
US12226505B2 (en) 2018-10-25 2025-02-18 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
MX2022005533A (es) 2019-12-06 2022-06-08 Procter & Gamble Composicion libre de sulfato con deposito mejorado del activo para el cuero cabelludo.
US11679065B2 (en) 2020-02-27 2023-06-20 The Procter & Gamble Company Compositions with sulfur having enhanced efficacy and aesthetics
JP7678101B2 (ja) 2020-11-23 2025-05-15 ザ プロクター アンド ギャンブル カンパニー 硫酸化界面活性剤を含まないパーソナルケア組成物
US11819474B2 (en) 2020-12-04 2023-11-21 The Procter & Gamble Company Hair care compositions comprising malodor reduction materials
US12409125B2 (en) 2021-05-14 2025-09-09 The Procter & Gamble Company Shampoo compositions containing a sulfate-free surfactant system and sclerotium gum thickener
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
US12458575B2 (en) 2021-12-09 2025-11-04 The Procter & Gamble Company Sulfate free personal cleansing composition comprising effective preservation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106106A0 (en) * 1993-06-22 1993-10-20 Interpharm Lab Ltd Library of polymeric molecules and its preparation
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
WO2000012553A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof

Also Published As

Publication number Publication date
HUP0103265A2 (hu) 2002-02-28
CZ2001655A3 (cs) 2001-11-14
WO2000012553A1 (en) 2000-03-09
JP2002523518A (ja) 2002-07-30
CN1324367A (zh) 2001-11-28
ZA200102489B (en) 2002-06-04
JP2010150272A (ja) 2010-07-08
JP4528443B2 (ja) 2010-08-18
PL204359B1 (pl) 2010-01-29
KR20010079695A (ko) 2001-08-22
HUP0103265A3 (en) 2002-09-30
IL141586A0 (en) 2002-03-10
PL346346A1 (en) 2002-02-11
AU751034B2 (en) 2002-08-08
CA2341810A1 (en) 2000-03-09
AU5690599A (en) 2000-03-21
EP1105420A1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
BR9913490A (pt) Prosaposina cìclicos e seus usos
EP0624348A3 (en) Bipolar electrosurgical instruments.
EP0600470A3 (en) Bipolar membrane.
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
DE69927956D1 (de) Shampoo zusammensetzungen auf basis von silikon
FI955866A0 (fi) Poishuuhdeltavat vesi öljyssä vedessä -koostumukset
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
DE69210683D1 (de) Endoskopische, bipolare elektrochirurgische Instrumente
BR0109943A (pt) Composições farmacêuticas
FR2705356B1 (fr) Compositions d'adhésif de pression de silicone.
ES2081870T3 (es) Composiciones polipropilenicas plasto-elasticas.
MX9206423A (es) Composicion de perfume.
IT1302347B1 (it) Procedimento per la produzione diretta di perossido di idrogeno.
DE69723277D1 (de) Dampfsterilisierungsanzeigdende zusammensetzungen
DE59401899D1 (de) Längenverstellbare Säule für Stühle, Tische o.dgl.
ITTO930346A0 (it) Procedimento per la preparazione di derivati taurocolanici.
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
MX9204623A (es) Compuesto de bis-4-piperidil-fosfita n-metilada.
GT199900062A (es) Preparados efervescentes.
BG100248A (bg) Инхибитори на скваленсинтетаза
ES2134064T3 (es) Extracto de harpagophytum procumbens rico en harpagosido y procedimiento para su preparacion.
DE69831737D1 (de) Neurotrypsin
IT1303736B1 (it) Peptidi derivati da rantes con attivita' anti-hiv.

Legal Events

Date Code Title Description
PC Transfer

Free format text: MYLS ACQUISITIONS CORP (US)

TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.